Thus, these findings suggest that Kaiso is a regulator of the THBS1/CD47/SIRPA signaling axis, thereby modulating immune signaling by exosomes to evade immune surveillance, particularly in AA breast cancers. Here, ZBTB33 is linked to breast carcinoma.